Market by Gender, Indications, Treatment Type, Sales Channel, and Country | Forecast 2021-2028
An analysis by Triton Market
suggests that the hair loss treatment market in the Asia-Pacific is likely to
progress with a CAGR of 5.84% over the projected years 2021-2028.
Report scope can be customized per your requirements. Request For Customization
The countries considered in
this market include:
•          China
•          India
•          Japan
•          South Korea
•          Australia & New Zealand
•          ASEAN countries
•          Rest of Asia-Pacific
Baldness is becoming
increasingly common among the Chinese, with nearly 250 million people suffering
from hair loss. Estimates from the China Association of Health Promotion and
Education (CAHEP) suggest that, men aged between 20 to 40 years are the main
group affected by this problem. They are conscious of their looks, and
therefore, many of them have turned to hair transplant surgery. The growing
number of people suffering from hair loss has increased the adoption of wig and
hair transplant methods, which has enhanced the demand for hair loss treatment.
This is fueling the hair loss treatment market growth in China.
In Japan, nearly 18 million
men are affected by some form of baldness, primarily in the area from the
forehead to the top of the scalp. Hereditary factors, as well as male hormonal
problems, are factors responsible for this condition. Also, the Japanese are at
a 28% risk of developing cancer before 75 years of age. The after-effects of
cancer treatment cause increased hair loss, therefore leading to an increase in
the cases of alopecia.
All these factors are raising
the demand for alopecia treatment in the country. Besides, Japan is known for
its medical innovation, and companies based here, such as Shiseido Company and
RIKEN Center for Biosystems Dynamics, are continuously working on the medical
treatment for this condition. In addition, the stress-inducing lifestyle is
another major factor contributing to the hair loss problem in Japan. The
above-stated factors are aiding the growth of the country’s hair loss treatment
market.
Taisho Pharmaceutical Co Ltd
is a pharmaceutical company engaged in developing, manufacturing, and marketing
various prescription pharmaceuticals and self-medication drugs. Some of the
products in the company’s portfolio include Riup, Lipovitan D, Clarith, Pabron,
Taisho Kampo Ichoyaku, Zosyn, Palux, and others. Its business segments include Prescription
Pharmaceuticals, Self-Medication, and Overseas Development. Taisho markets its
products via a network of distributors in the Philippines, Malaysia, Indonesia,
Hong Kong, Thailand, Australia, Taiwan, the UK, the US, China, and Vietnam. It is
headquartered in Tokyo, Japan.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. ASIA-PACIFIC
HAIR LOSS TREATMENT MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE HAIR LOSS TREATMENT INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. EFFORTS
TO DEVELOP STEM CELL HAIR TRANSPLANTATION METHOD
2.2.2. DEVELOPMENT
OF ROBOT HAIR RESTORATION SYSTEM
2.2.3. INTENSIVE
RESEARCH ON 3D PRINTING TECHNOLOGY FOR HAIR
2.3. PORTER’S
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
DEVELOPMENTS
2.6.3. CONTRACTS
& AGREEMENTS
2.6.4. INVESTMENT
& EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISE
IN CASES OF AUTOIMMUNE DISEASE
2.7.2. HIGH
CONSUMPTION OF ALCOHOL AND TOBACCO
2.7.3. UNHEALTHY
DIETARY HABITS
2.7.4. STRESS
AND CHANGING LIFESTYLES
2.8. MARKET
CHALLENGES
2.8.1. RISK
OF INFECTION OR SIDE EFFECTS
2.8.2. HIGH
COST OF TREATMENT
2.9. MARKET
OPPORTUNITIES
2.9.1. R&D
IN HAIR CLONING TECHNOLOGY
2.9.2. DEVELOPMENT
OF BARICITINIB
3. ASIA-PACIFIC
HAIR LOSS TREATMENT MARKET OUTLOOK – BY GENDER
3.1. FEMALE
3.2. MALE
4. ASIA-PACIFIC
HAIR LOSS TREATMENT MARKET OUTLOOK – BY INDICATIONS
4.1. ANDROGENIC
ALOPECIA
4.2. ALOPECIA
AREATA
4.3. ALOPECIA
TOTALIS
4.4. OTHER
INDICATIONS
5. ASIA-PACIFIC
HAIR LOSS TREATMENT MARKET OUTLOOK – BY TREATMENT TYPE
5.1. TOPICAL
HAIR LOSS TREATMENT,
5.1.1. MINOXIDIL
5.1.2. SHAMPOOS
5.2. ORAL
HAIR LOSS TREATMENT
5.2.1. FINASTERIDE
5.2.2. OTHER
ORAL HAIR LOSS TREATMENT
5.3. OTHER
TREATMENT TYPES
6. ASIA-PACIFIC
HAIR LOSS TREATMENT MARKET OUTLOOK – BY SALES CHANNEL
6.1. DRUG
STORES & RETAIL PHARMACIES
6.2. HOSPITAL
PHARMACIES
6.3. ONLINE
PHARMACIES
7. ASIA-PACIFIC
HAIR LOSS TREATMENT MARKET– REGIONAL OUTLOOK
7.1. CHINA
7.2. JAPAN
7.3. INDIA
7.4. SOUTH
KOREA
7.5. ASEAN
COUNTRIES
7.6. AUSTRALIA
& NEW ZEALAND
7.7. REST
OF ASIA-PACIFIC
8. COMPETITIVE
LANDSCAPE
9. COMPETITIVE
LANDSCAPE
9.1. TEVA
PHARMACEUTICALS
9.2. MERCK
& CO
9.3. CIPLA
LIMITED
9.4. JOHNSON
& JOHNSON
9.5. SUN
PHARMACEUTICAL INDUSTRIES LTD
9.6. CONCERT
PHARMACEUTICALS INC
9.7. SHISEIDO
COMPANY LIMITED
9.8. TAISHO
PHARMACEUTICAL CO LTD
9.9. DR
REDDYS LABORATORIES
9.10. THE
HIMALAYA DRUG COMPANY
9.11. TRANSITIONS
HAIR PVT LTD
9.12. LEXINGTON
INTERNATIONAL LLC
9.13. ACLARIS
THERAPEUTICS
9.14. CELLMID
9.15. DAIICHI
SANKYO
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE 1: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS
& AGREEMENTS
TABLE 6: LIST OF INVESTMENT
& EXPANSIONS
TABLE 7: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 8: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 9: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: ASIA-PACIFIC HAIR LOSS
TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 13: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: PREVALENCE OF
DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES IN 2019
FIGURE 3: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)
FIGURE 4: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 5: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 6: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY INDICATIONS, 2020 & 2028 (IN %)
FIGURE 7: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
FIGURE 8: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
FIGURE 9: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
FIGURE 10: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY TREATMENT TYPE, 2020 & 2028 (IN %)
FIGURE 12: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 13: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
FIGURE 14: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
FIGURE 15: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
FIGURE 16: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ORAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 17: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 18: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
FIGURE 19: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 20: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY OTHERÂ TREATMENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 21: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY SALES CHANNEL, 2020 & 2028 (IN %)
FIGURE 22: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 23: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 24: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 25: ASIA-PACIFIC HAIR
LOSS TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 26: CHINA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: JAPAN HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: INDIA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: SOUTH KOREA HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: ASEAN COUNTRIES
HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: AUSTRALIA & NEW
ZEALAND HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: REST OF
ASIA-PACIFIC HAIR LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)